Cargando…

Validation of conventional non-invasive fibrosis scoring systems in patients with metabolic associated fatty liver disease

BACKGROUND: Non-invasive fibrosis scores are not yet validated in the newly defined metabolic associated fatty liver disease (MAFLD). AIM: To evaluate the diagnostic performance of four non-invasive scores including aspartate aminotransferase to platelet ratio index (APRI), fibrosis-4 index (FIB-4),...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wu, Yin-Lian, Kumar, Rahul, Wang, Ming-Fang, Singh, Medha, Huang, Jiao-Feng, Zhu, Yue-Yong, Lin, Su
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Baishideng Publishing Group Inc 2021
Materias:	Retrospective Study
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8473595/ https://www.ncbi.nlm.nih.gov/pubmed/34629799 http://dx.doi.org/10.3748/wjg.v27.i34.5753

Ejemplares similares

Validation model of fibrosis-8 index score to predict significant fibrosis among patients with nonalcoholic fatty liver disease
por: Prasoppokakorn, Thaninee, et al.
Publicado: (2022)

Clinic-pathological features of metabolic associated fatty liver disease with hepatitis B virus infection
por: Wang, Ming-Fang, et al.
Publicado: (2021)

Development of a novel score for the diagnosis of bacterial infection in patients with acute-on-chronic liver failure
por: Lin, Su, et al.
Publicado: (2020)

Fibrosis in nonalcoholic fatty liver disease: Noninvasive assessment using computed tomography volumetry
por: Fujita, Nobuhiro, et al.
Publicado: (2016)

Validation of Non-invasive Fibrosis Scores for Predicting Advanced Fibrosis in Metabolic-associated Fatty Liver Disease
por: Chen, Xiaoning, et al.
Publicado: (2022)

Comments on validation of conventional non-invasive fibrosis scoring systems in patients with metabolic associated fatty liver disease
por: Hong, Jian-Guo, et al.
Publicado: (2022)

Serum autotaxin levels are correlated with hepatic fibrosis and ballooning in patients with non-alcoholic fatty liver disease
por: Fujimori, Naoyuki, et al.
Publicado: (2018)

Mild drinking habit is a risk factor for hepatocarcinogenesis in non-alcoholic fatty liver disease with advanced fibrosis
por: Kimura, Takefumi, et al.
Publicado: (2018)

End-stage liver disease score and future liver remnant volume predict post-hepatectomy liver failure in hepatocellular carcinoma
por: Kong, Fan-Hua, et al.
Publicado: (2019)

Liver function tests and metabolic-associated fatty liver disease: Changes in upper normal limits, does it really matter?
por: Forlano, Roberta, et al.
Publicado: (2021)

Development and validation of a prognostic nomogram for decompensated liver cirrhosis
por: Zhang, Wang, et al.
Publicado: (2022)

Value of pretransplant albumin-bilirubin score in predicting outcomes after liver transplantation
por: Ma, Tao, et al.
Publicado: (2019)

Development and validation of a prediction model for microvascular invasion in hepatocellular carcinoma
por: Wang, Lin, et al.
Publicado: (2020)

Serum ceruloplasmin can predict liver fibrosis in hepatitis B virus-infected patients
por: Kang, Na-Ling, et al.
Publicado: (2020)

Clinical characteristics of non-alcoholic fatty liver disease in Chinese adult hypopituitary patients
por: Yuan, Xian-Xian, et al.
Publicado: (2019)

Influence of non-alcoholic fatty liver disease on non-variceal upper gastrointestinal bleeding: A nationwide analysis
por: Soni, Aakriti, et al.
Publicado: (2023)

Effect of liver inflammation on accuracy of FibroScan device in assessing liver fibrosis stage in patients with chronic hepatitis B virus infection
por: Huang, Ling-Ling, et al.
Publicado: (2021)

Serum N-glycan markers for diagnosing liver fibrosis induced by hepatitis B virus
por: Cao, Xi, et al.
Publicado: (2020)

Sex-influenced association of non-alcoholic fatty liver disease with colorectal adenomatous and hyperplastic polyps
por: Chen, Qin-Fen, et al.
Publicado: (2017)

Towards an evaluation of alcoholic liver cirrhosis and nonalcoholic fatty liver disease patients with hematological scales
por: Michalak, Agata, et al.
Publicado: (2020)

Risk factors for hepatic steatosis in adults with cystic fibrosis: Similarities to non-alcoholic fatty liver disease
por: Ayoub, Fares, et al.
Publicado: (2018)

Peptic ulcer disease in non-alcoholic fatty liver disease hospitalizations: A new challenge on the horizon in the United States
por: Dahiya, Dushyant Singh, et al.
Publicado: (2023)

Association of non-alcoholic fatty liver disease with gallstone disease in the United States hospitalized patient population
por: Kichloo, Asim, et al.
Publicado: (2021)

Comparative study of indocyanine green-R15, Child-Pugh score, and model for end-stage liver disease score for prediction of hepatic encephalopathy after transjugular intrahepatic portosystemic shunt
por: Wang, Zhong, et al.
Publicado: (2021)

Effects of proprotein convertase subtilisin/kexin type-9 inhibitors on fatty liver
por: Shafiq, Muhammad, et al.
Publicado: (2020)

Validated model for prediction of recurrent hepatocellular carcinoma after liver transplantation in Asian population
por: Ma, Ka Wing, et al.
Publicado: (2019)

Optimized protocol of multiple post-processing techniques improves diagnostic accuracy of multidetector computed tomography in assessment of small bowel obstruction compared with conventional axial and coronal reformations
por: Kuang, Lian-Qin, et al.
Publicado: (2019)

Validation of the six-and-twelve criteria among patients with hepatocellular carcinoma and performance score 1 receiving transarterial chemoembolization
por: Wang, Zhe-Xuan, et al.
Publicado: (2020)

Prediction of colorectal tumor grade and invasion depth through narrow-band imaging scoring
por: Maeyama, Yasuhiko, et al.
Publicado: (2018)

Comparison of dental pulp periodontal therapy and conventional simple periodontal therapy as treatment modalities for severe periodontitis
por: Li, Lu, et al.
Publicado: (2021)

Predicting gastroesophageal varices through spleen magnetic resonance elastography in pediatric liver fibrosis
por: Yoon, Haesung, et al.
Publicado: (2019)

Medications in type-2 diabetics and their association with liver fibrosis
por: Siddiqui, Mohamed Tausif, et al.
Publicado: (2020)

Liver intravoxel incoherent motion diffusion-weighted imaging for the assessment of hepatic steatosis and fibrosis in children
por: Shin, Hyun Joo, et al.
Publicado: (2018)

Use of aspartate aminotransferase to platelet ratio to reduce the need for FibroScan in the evaluation of liver fibrosis
por: Wong, Stephanie, et al.
Publicado: (2017)

Novel index for the prediction of significant liver fibrosis and cirrhosis in chronic hepatitis B patients in China
por: Liao, Min-Jun, et al.
Publicado: (2022)

Development and validation of a risk prediction score for the severity of acute hypertriglyceridemic pancreatitis in Chinese patients
por: Liu, Zi-Yu, et al.
Publicado: (2022)

Role of micronutrients in staging of nonalcoholic fatty liver disease: A retrospective cross-sectional study
por: Bertol, Franciele Sabadin, et al.
Publicado: (2020)

Association of maternal obesity and gestational diabetes mellitus with overweight/obesity and fatty liver risk in offspring
por: Zeng, Jing, et al.
Publicado: (2022)

Declining diagnostic accuracy of non-invasive fibrosis tests is associated with elevated alanine aminotransferase in chronic hepatitis B
por: Wang, Lin, et al.
Publicado: (2018)

Validation of modified albumin-bilirubin-TNM score as a prognostic model to evaluate patients with hepatocellular carcinoma
por: Elshaarawy, Omar, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_ao1gdp92l2pv8pcp0ol2q0o4gp